Abiomed (ABMD) Director Buys 100K Shares
- Wall St stumbles as FBI to review more Clinton emails
- FBI to review more emails related to Clinton's private email use
- ExxonMobil (XOM) Tops Q3 EPS by 5c; CapEx Light of Views
- Baker Hughes (BHI), General Electric (GE) in Partnership Talks, Not Merger Talks
- AbbVie (ABBV) Tops Q3 EPS by 1c; Boosts FY16 EPS Outlook
Abiomed, Inc. (NASDAQ: ABMD) Director, Henri Termeer, disclosed the purchase of 100,000 shares from 2/22-2/25 at prices from $14.6955-$15.1997, bringing his stake to 172,398 shares.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Abiomed (ABMD) Misses Q2 EPS by 4c; Maintains Revenue Outlook
- Cree (CREE) CEO Buys 10K Shares
- Cree (CREE) Sees Continued Insider Buying; Director Buys 10K Shares
Create E-mail Alert Related CategoriesInsider Trades
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!